Evidence map›Paper›PMID 28555385›Full record

ReviewSeminars in immunopathology2017

Cytokine storm and sepsis disease pathogenesis.

Benjamin G Chousterman, Filip K Swirski, Georg F Weber

2 registry-linked trialsAbstract readReview
PubMed Publisher
In one paragraph

Review in Seminars in immunopathology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 758 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
758citing papers in PubMed, 1 pooled it
35.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04865029 phase2terminatednot on this mapstarted 2021, after this paper: background citation

Acute Estradiol and Progesterone Therapy in Hospitalized Adults to Reduce Coronavirus Disease (COVID-19) Severity: A Randomized Control Trial

TypeinterventionalSponsorTulane UniversityRan2021 to 2022Enrolled10ConditionsCovid19ArmsPlacebo injection and placebo pill, Estradiol Cypionate 5 mg/ml, Progesterone 200 mg Oral Capsule
NCT05941624 nacompletednot on this mapstarted 2023, after this paper: background citation

Comparison Between HA330 Hemoperfusion Filter Hemodialysis and Conventional High-Flux Filter Hemodialysis in Reducing Inflammatory Mediators in Renal Dysfunction Due to Sepsis

TypeinterventionalSponsorIndonesia UniversityRan2023 to 2024Enrolled33ConditionsRenal Dysfunction, Sepsis, HemodialysisArmsHa-330 Hemoperfusion Filter Hemodialysis, Conventional Hemodialysis
3 · Its place in the literature

Who cites it

758 citing papers in PubMed, 1 synthesis or guideline pooled it, 1,312 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Update on sepsis treatment.Journal of intensive care · 2026
    Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Decoding Host-Pathogen Dynamics inAntibiotics (Basel, Switzerland) · 2026
    Review
  19. Review
  20. Article

698 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 3 countries.

Benjamin G ChoustermanDépartement d'Anesthésie-Réanimation, Hôpitaux Universitaires Lariboisière-Saint-Louis, AP-HP, Paris, France. benjamin.chousterman@aphp.fr.
Filip K SwirskiCenter for Systems Biology, Department of Imaging, Massachusetts General Hospital, Harvard Medical School, Boston, MA, 02114, USA.
Georg F WeberDepartment of Surgery, University of Erlangen-Nürnberg, Erlangen, Germany.
Assistance Publique – Hôpitaux de Paris · FRFriedrich-Alexander-Universität Erlangen-Nürnberg · DEHarvard University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Infectious diseases are a leading cause of death worldwide. Sepsis is a severe clinical syndrome related to the host response to infection. The severity of infections is due to an activation cascade that will lead to an autoamplifying cytokine production: the cytokine storm. Cytokines are a broad category of relatively small proteins (<40 kDa) that are produced and released with the aim of cell signaling. Our understanding of the processes that trigger this tremendous amount of cytokine production has made dramatic progress over the last decades, but unfortunately, these findings could not translate yet into effective treatments; so far, all clinical trials targeting cytokine production or effects failed. This review aims to summarize the pathophysiology of the cytokine storm; to describe the type, effects, and kinetics of cytokine production; and to discuss the therapeutic challenges of targeting cytokines. New promising therapeutic strategies focusing on the endothelium, as a source and a target of cytokines, are described.

Indexed as

AnimalsBiomarkersCytokinesEndotheliumGenetic Predisposition to DiseaseHumansImmune SystemImmunity, InnateInflammation MediatorsPolymorphism, GeneticSepsisSignal TransductionBiomarkersCytokinesInflammation MediatorsCytokineEndotheliumInflammationInnate immunitySepsis

Identifiers

PMID28555385
OpenAlexW2617620062

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.